Bioinformatic Approaches in Neurodegenerative Diseases

Zhuozhi Liu

doi:10.62051/kpfb4b76

Authors

Zhuozhi Liu

DOI:

https://doi.org/10.62051/kpfb4b76

Keywords:

Neurodegenerative Diseases; Bioinformatics; applications of bioinformatics.

Abstract

Neurodegenerative diseases (NDDs), including Alzheimer's and Parkinson's, affect the central nervous system, causing progressive loss of cognitive and motor functions. As the global population ages, the prevalence of NDDs rises, imposing significant burdens on patients, families, and society. Despite extensive research, the diagnosis and treatment of NDDs remain challenging due to the complexity of their pathological mechanisms. Traditional methods, such as experimental biology and clinical observation, offer insights but are limited in scope. Bioinformatics, an interdisciplinary field combining biology, computer science, and information technology, provides new opportunities for advancing NDD research. It facilitates the analysis of genomics and proteomics data, aids in drug discovery, and enhances the construction of disease models. This study explores the applications of bioinformatics in NDD research, highlighting its role in identifying disease-associated genes, understanding molecular mechanisms, and discovering potential therapies. Case studies demonstrate how bioinformatics tools can improve research outcomes. The study concludes with a discussion on future research directions and the potential of bioinformatics to develop novel diagnostic and therapeutic approaches for NDDs. Continued advancements in bioinformatics and interdisciplinary collaboration are expected to deepen our understanding of these diseases and lead to more effective treatments.

Downloads

Download data is not yet available.

References

[1] Du, R.-Q., Jin, L., & Zhang, F. (2011). Copy number variations in the human genome: Their mutational mechanisms and roles in diseases. HEREDITAS, 33(8), 857-869.

[2] Wang, X.-C., Yang, Z.-R., Wang, M., Li, W., & Li, S.-C. (2012). High-throughput sequencing technology and its application. China Biotechnology, 32(1), 109-114.

[3] Wang, J., Kong, L., Gao, G., & Luo, J. (2013). A brief introduction to web-based genome browsers. Briefings in Bioinformatics, 14(2), 131-143. https://doi.org/10.1093/bib/bbs029

[4] Crowe, M. L. (2005). SeqDoC: Rapid SNP and mutation detection by direct comparison of DNA sequence chromatograms. BMC Bioinformatics, 6, 133. https://doi.org/10.1186/1471-2105-6-133

[5] Wang, Q., Jia, P., & Li, F., et al. (2013). Detecting somatic point mutations in cancer genome sequencing data: A comparison of mutation callers. Genome Medicine, 5, 91. https://doi.org/10.1186/gm495

[6] Crowe, M. L. (2005). SeqDoC: Rapid SNP and mutation detection by direct comparison of DNA sequence chromatograms. BMC Bioinformatics, 6(1), 1-12.

[7] Xu, J., Yang, P., Xue, S., Sharma, B., Sanchez-Martin, M., Wang, F., ... & Parikh, B. (2019). Translating cancer genomics into precision medicine with artificial intelligence: Applications, challenges and future perspectives. Human Genetics, 138(2), 109-124.

[8] Ma, S., Wei, M., Ni, J., Li, T., Wang, X., Xu, S., & Li, X. (2019). Meta-analysis of the association between APOE e4 allele and psychobehavioral symptoms in Alzheimer's disease. China Medical Journal, 19(23), 79-84.

[9] Yuan, X., Yao, C., Chen, W., Wang, J., Huang, Y., Qu, Y., Zeng, H., Cui, E., & Liao, Y. (2024). Recent advance in different therapies for Alzheimer's disease. Guangzhou Medical Journal, 55(3), 236-244.

[10] Chen, C., Hou, J., Tanner, J. J., & Cheng, J. (2020). Bioinformatics methods for mass spectrometry-based proteomics data analysis. International Journal of Molecular Sciences, 21(8), 2873.

[11] Johri, A., & Beal, M. F. (2012). Mitochondrial dysfunction in neurodegenerative diseases. Journal of Pharmacology and Experimental Therapeutics, 342(3), 619-630.

[12] Butterfield, D. A. (2004). Proteomics: A new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Research, 1000(1-2), 1-7.

[13] Durães, F., Pinto, M., & Sousa, E. (2018). Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals, 11(2), 44.

[14] Surana, K. R., Ahire, E. D., Sonawane, V. N., & Talele, S. G. (2021). Biomolecular and molecular docking: A modern tool in drug discovery and virtual screening of natural products. In Applied Pharmaceutical Practice and Nutraceuticals (pp. 209-223). Apple Academic Press.

[15] Surana, K. R., Ahire, E. D., Sonawane, V. N., & Talele, S. G. (2021). Biomolecular and molecular docking: A modern tool in drug discovery and virtual screening of natural products. In Applied Pharmaceutical Practice and Nutraceuticals (pp. 209-223). Apple Academic Press.

[16] Abbas, Z., Tayara, H., & Chong, K. T. (2022). Alzheimer's disease prediction based on continuous feature representation using multi-omics data integration. Chemometrics and Intelligent Laboratory Systems, 223, 104536.

[17] Wood, L. B., Winslow, A. R., & Strasser, S. D. (2015). Systems biology of neurodegenerative diseases. Integrative Biology, 7(7), 758-775.

[18] Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682-690.

[19] Benton, D. (1996). Bioinformatics: Principles and potential of a new multidisciplinary tool. Trends in Biotechnology, 14(8), 261-272.